E-LIB Suche - Ergebnisse für: Paradkar, Vikram

1

Immunogenicity and safety of Biological E's CORBEVAX™ vacci..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
Human Vaccines & Immunotherapeutics. 19 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

2

Conference report: WHO meeting summary on mRNA-based tuberc..:

Looney, Monika M. ; Hatherill, Mark ; Musvosvi, Munyaradzi...
Vaccine. 41 (2023) 48 - p. 7060-7066 , 2023

Link: https://doi.org/10.1016/..

3

Receptor-binding domain recombinant protein on alum-CpG ind..:

Pollet, Jeroen ; Strych, Ulrich ; Chen, Wen-Hsiang...
Vaccine. 40 (2022) 26 - p. 3655-3663 , 2022

Link: https://doi.org/10.1016/..

4

Safety, tolerability and immunogenicity of Biological E's C..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
Vaccine. 40 (2022) 49 - p. 7130-7140 , 2022

Link: https://doi.org/10.1016/..

5

Evaluation of safety and immunogenicity of receptor-binding..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, Subba Reddy...
eBioMedicine. 83 (2022) - p. 104217 , 2022

Link: https://doi.org/10.1016/..

6

A multicenter, single-blind, randomized, phase-2/3 study to..:

Thuluva, Subhash ; Paradkar, Vikram ; Matur, Ramesh..
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

7

High-yield production of a human therapeutic protein in tob..:

Staub, Jeffrey M. ; Garcia, Bradley ; Graves, Julie...
Nature Biotechnology. 18 (2000) 3 - p. 333-338 , 2000

Link: https://doi.org/10.1038/..

8

Host limits to accurate human growth hormone production in ..:

Russell, Douglas A. ; Spatola, Lori A. ; Dian, Titik...
Biotechnology and Bioengineering. 91 (2005) 4 - p. 522-522 , 2005

Link: https://doi.org/10.1002/..

9

Host limits to accurate human growth hormone production in ..:

Russell, Douglas A. ; Spatola, Lori A. ; Dian, Titik...
Biotechnology and Bioengineering. 89 (2005) 7 - p. 775-782 , 2005

Link: https://doi.org/10.1002/..

10

A humanized monoclonal antibody produced in transgenic plan..:

Zeitlin, Larry ; Olmsted, Stuart S. ; Moench, Thomas R....
Nature Biotechnology. 16 (1998) 13 - p. 1361-1364 , 1998

Link: https://doi.org/10.1038/..

11

Peptide synthesis using proteases dissolved in organic solv..:

Sergeeva, Maria V. ; Paradkar, Vikram M. ; Dordick, Jonathan S.
Enzyme and Microbial Technology. 20 (1997) 8 - p. 623-628 , 1997

Link: https://doi.org/10.1016/..

12

Mechanism of extraction of chymotrypsin into isooctane at v..:

Paradkar, Vikram M. ; Dordick, Jonathan S.
Biotechnology and Bioengineering. 43 (1994) 6 - p. 529-540 , 1994

Link: https://doi.org/10.1002/..

13

Immunogenicity and safety of Biological E's CORBEVAX™ vacci..:

Thuluva, Subhash ; Paradkar, Vikram ; Gunneri, SubbaReddy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294721/. , 2023

Link: http://www.ncbi.nlm.nih...

14

A multicenter, single-blind, randomized, phase-2/3 study to..:

Thuluva, Subhash ; Paradkar, Vikram ; Matur, Ramesh..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196756/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Receptor-binding domain recombinant protein on alum-CpG ind..:

Pollet, Jeroen ; Strych, Ulrich ; Chen, Wen-Hsiang...
Pollet, Jeroen, Strych, Ulrich, Chen, Wen-Hsiang, et al. "Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern." Vaccine, 40, no. 26 (2022) Elsevier: 3655-3663. https://doi.org/10.1016/j.vaccine.2022.05.007.. , 2022

Link: https://hdl.handle.net/1..